BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cellectis 

8 rue de la Croix Jarry

Paris    75013  France
Phone: 33-0-1-81-69-16-00 Fax: n/a


SEARCH JOBS




Industry
Biotechnology

Segment
Genomics





 Company News
Cellectis Announces The Closing Of €20.5 Million Share Capital Increase Subscribed On March 24, 2014 By U.S. Biotechnology Specialist Institutional Investors 4/1/2014 6:56:05 AM    More...
Cellectis, Servier Forge Leukemia, Solid Tumors Pact To Battle With Novartis AG (NVS) And Newbie Juno Therapeutics 2/18/2014 7:39:15 AM    More...
U.S. Patent Institutions Recognize The Patentability Of Institut Pasteur/Cellectis Early Inventions On Meganucleases 2/5/2014 10:07:15 AM    More...
Cellectis Grants genOway An Exclusive Sublicense For Its Homologous Recombination Technology In The Field Of Genetically Modified Rodent Models 2/4/2014 11:47:36 AM    More...
Cellectis Reorganizes Its Tools And Services Business Line, In Partnership With Caisse Des Dépôts, By Contributing Ectycell’s Shares To Cellectis Bioresearch 1/7/2014 10:52:36 AM    More...
Cellectis Announces Groundbreaking in Vivo Proof of Concept Testing of Their Flagship UCART19 Product for Curative Therapy of Leukemia 7/8/2013 10:35:04 AM    More...
Cellectis Combined General Shareholders’ Meeting of June 14, 2013 6/18/2013 12:20:27 PM    More...
TAL-Effector Nuclease: The USPTO Issues a Third Patent Licensed to Cellectis 5/28/2013 11:11:46 AM    More...
Cellectis: TAL-effector Nuclease: Issuance by the USPTO of Two New Patents 5/16/2013 10:54:25 AM    More...
Precision BioSciences Wins Patent Infringement Lawsuit Against Cellectis 5/6/2013 10:17:37 AM    More...
12345678910...